(Q48029222)

7 February 2018

title

Pharmacotherapy for preeclampsia in low and middle income countries: an analysis of essential medicines lists (English)

1 reference

7 February 2018

0 references

0 references

8

1 reference

7 February 2018

Laura A Magee

3

Laura A Magee

1 reference

7 February 2018

Beth Payne

5

Beth Payne

1 reference

7 February 2018

Tabassum Firoz

2

Tabassum Firoz

1 reference

7 February 2018

Diane Sawchuck

4

Diane Sawchuck

1 reference

7 February 2018

Shifana Lalani

1

Shifana Lalani

1 reference

7 February 2018

author name string

Rebecca Gordon

6

1 reference

7 February 2018

Marianne Vidler

7

1 reference

7 February 2018

Community Level Interventions for Pre-eclampsia (CLIP) Working Group

9

1 reference

7 February 2018

publication date

1 March 2013

1 reference

7 February 2018

Journal of Obstetrics and Gynaecology Canada

published in

1 reference

7 February 2018

volume

35

1 reference

7 February 2018

issue

3

1 reference

7 February 2018

page(s)

215-223

1 reference

7 February 2018

WHO analysis of causes of maternal death: a systematic review

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930993-2

7 January 2021

The global impact of pre-eclampsia and eclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930993-2

7 January 2021

What matters in preeclampsia are the associated adverse outcomes: the view from Canada

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930993-2

7 January 2021

Pre-eclampsia in low and middle income countries

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930993-2

7 January 2021

25 years of the WHO essential medicines lists: progress and challenges

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930993-2

7 January 2021

Adding a medicine to the WHO model list of essential medicines

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930993-2

7 January 2021

Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930993-2

7 January 2021

Translating research into policy and practice in developing countries: a case study of magnesium sulphate for pre-eclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930993-2

7 January 2021

System and market failures: the unavailability of magnesium sulphate for the treatment of eclampsia and pre-eclampsia in Mozambique and Zimbabwe

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930993-2

7 January 2021

Prices of antihypertensive medicines in sub-Saharan Africa and alignment to WHO's model list of essential medicines

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930993-2

7 January 2021

Diagnosis, Evaluation, and Management of the Hypertensive Disorders of Pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930993-2

7 January 2021

Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930993-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930993-2

1 reference

7 January 2021

Cardiovascular alterations in severe pregnancy-induced hypertension: acute effects of intravenous magnesium sulfate.

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930993-2

7 January 2021

Effect of magnesium sulfate on cardiovascular hemodynamics

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930993-2

7 January 2021

Prices, availability and affordability of essential medicines in rural areas of Hubei Province, China.

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930993-2

7 January 2021

Applying human rights to improve access to reproductive health services

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930993-2

7 January 2021

10.1016/S1701-2163(15)30993-2

Identifiers

DOI

1 reference

7 February 2018

1 reference

7 February 2018